TS News
Tenaris S.A.
$61.27
+$0.33(+0.54%)
70
Overall
100
Value
63
Tech
47
Quality
Market Cap
$32.44B
Volume
488.53K
52W Range
$37.69 - $64.60
Target Price
$68.70
TS news: the latest Tenaris S.A. headlines, press releases and market updates, newest first.
Latest TS News
- Capital Markets Board Decisions Concern Kardemir Çelik Shares, Company SaysTipRanks Turkey Auto-Generated Newsdesk · Nov 15, 2026
- Kingland Property Announces Additional Endorsement for SubsidiaryTipRanks Taiwan Auto-Generated Newsdesk · Nov 15, 2026
- Baiyunshan Seeks Approval for GP Corp. Strategic Investor PlanTipRanks HongKong Auto-Generated Newsdesk · Nov 15, 2026
- JW (Cayman) Therapeutics Announces Conditional HK$160 Million Share SubscriptionTipRanks HongKong Auto-Generated Newsdesk · Nov 15, 2026
- Green Tea Group Reports Director Resignation and Listing-Rule Non-ComplianceTipRanks HongKong Auto-Generated Newsdesk · Nov 15, 2026
- Green Tea Group Board and Committee RolesTipRanks HongKong Auto-Generated Newsdesk · Nov 15, 2026
- China Parenting Network Proposes Loan Capitalisation and New Share IssueTipRanks HongKong Auto-Generated Newsdesk · Nov 15, 2026
- ICU Girişim Sermayesi Submitted September 2026 Income StatementTipRanks Turkey Auto-Generated Newsdesk · Nov 15, 2026
- Hengrui Announces Drug Inclusions in China’s 2026 NRDLTipRanks HongKong Auto-Generated Newsdesk · Nov 15, 2026
- Company Announces Proposed 11-for-1 Rights IssueTipRanks HongKong Auto-Generated Newsdesk · Nov 15, 2026
- Foxwell Power Announces Natural-Person Director ResignationTipRanks Taiwan Auto-Generated Newsdesk · Nov 15, 2026
- PegBio’s Paidakang Included in China’s 2026 NRDLTipRanks HongKong Auto-Generated Newsdesk · Nov 15, 2026
- Luye Pharma’s Ruoxinlin Renewed in China’s 2026 Reimbursement Drug ListTipRanks HongKong Auto-Generated Newsdesk · Nov 15, 2026
- Carteyva Included in 2026 National Reimbursement Drug ListTipRanks HongKong Auto-Generated Newsdesk · Nov 15, 2026
- Innovent adds seven products to China’s 2026 NRDLTipRanks HongKong Auto-Generated Newsdesk · Nov 15, 2026
- JY Grandmark Reports Default Borrowings and Weak Property SalesTipRanks HongKong Auto-Generated Newsdesk · Nov 15, 2026
- JW Therapeutics Plans Presentation on Carteyva® NRDL InclusionTipRanks HongKong Auto-Generated Newsdesk · Nov 15, 2026
- Henlius Announces HANSIZHUANG and FUTUONING Additions to 2026 NRDLTipRanks HongKong Auto-Generated Newsdesk · Nov 15, 2026
- Xuanzhu Biopharmaceutical’s New Bireociclib Indication Included in China’s 2026 NRDLTipRanks HongKong Auto-Generated Newsdesk · Nov 15, 2026
- Sunshine Lake Pharma’s Olorigliflozin Added to China’s 2026 Reimbursement ListTipRanks HongKong Auto-Generated Newsdesk · Nov 15, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TS | $61.27 | +0.5% | 488.53K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |